SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
142 hedge funds and large institutions have $1.82B invested in SpringWorks Therapeutics in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 68 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 148 → 142 (-6)
20% less call options, than puts
Call options by funds: $951K | Put options by funds: $1.2M
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
Holders
142
Holding in Top 10
5
Calls
$951K
Puts
$1.2M
Top Buyers
1 | +$28M | |
2 | +$26.8M | |
3 | +$26.6M | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.9M |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.2M |
Top Sellers
1 | -$34.1M | |
2 | -$14.2M | |
3 | -$14.1M | |
4 |
Victory Capital Management
San Antonio,
Texas
|
-$13.3M |
5 |
O
OrbiMed
New York
|
-$8.4M |